Medicine and Dentistry
Gemcitabine
100%
Pancreas Cancer
100%
Dendritic Cell
37%
Pancreas Tumor
37%
Neoplasm
37%
Natural Killer Cell
25%
Cancer Model
25%
Cytokine
25%
Cellular Immunity
25%
Immune Response
25%
Disease
12%
Tumor Cell
12%
Immunosuppressive Treatment
12%
Tumor Progression
12%
Cross Presentation
12%
T Lymphocyte
12%
Malignant Neoplasm
12%
T-Cell Response
12%
Clinical Trial
12%
Five-Year Survival Rate
12%
Keyphrases
FMS-like Tyrosine Kinase 3 (FLT3)
66%
Pancreatic Cancer
66%
Gemcitabine
48%
Pancreatic Tumor
18%
Dendritic Cells
18%
Immune Response
12%
Antitumor Effect
12%
Cancer Model
12%
Natural Killer Cells
12%
Antigen Cross-presentation
9%
Chemical Delivery System
9%
Cellular Immune Response
6%
Cause of Death
6%
Delivery Mat
6%
Cancer Patients
6%
Tumor Cells
6%
T Cell Response
6%
Clinical Trials
6%
5-year Survival
6%
Cellular Immunity
6%
Immunosuppression Reduction
6%
Cytokine Milieu
6%
T Cells
6%
New Adjuvants
6%
Treatment Strategy
6%
United States
6%
Specific Intent
6%
Synergize
6%
Illness
6%
Preclinical Animal Models
6%
Tumor Growth
6%
Cell-to-cell
6%
Tumor
6%
Biochemistry, Genetics and Molecular Biology
Gemcitabine
100%
Dendritic Cell
37%
Cellular Immunity
25%
T Cell
25%
Cytokine
25%
Natural Killer Cell
25%
Immune Response
25%
Cross Presentation
12%
Survival Rate
12%
Clinical Trial
12%
Mouse Model
12%
Tumor Progression
12%